Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study

Evaluation of the AID TB Resistance Line Probe Assay for Rapid Detection of Genetic Alterations Associated with Drug Resistance in Mycobacterium tuberculosis Strains

(2014) C. Ritter et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

(2014) Elize Pietersen et al.   LANCET

Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis

(2013) Aurélie Fillion et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union

(2013) C Bernard et al.   Eurosurveillance

Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis

(2013) A. Martin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis?

(2013) D. B. Folkvardsen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks

(2013) Frederick A. Sirgel et al.   PLoS One

Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance Testing

(2012) E. M. Streicher et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system

(2012) Fernanda Maruri et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phenylethyl Butyrate Enhances the Potency of Second-Line Drugs against Clinical Isolates of Mycobacterium tuberculosis

(2011) Thomas Grau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The ins and outs of Mycobacterium tuberculosis drug susceptibility testing

(2011) E.C. Böttger   CLINICAL MICROBIOLOGY AND INFECTION

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis

(2011) T. Schön et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge [Short communication]

(2011) J. van Ingen et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide

(2011) Stéphanie Petrella et al.   PLoS One

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

(2010) K. A. Angeby et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates

(2010) F. Brossier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

(2010) Neel R Gandhi et al.   LANCET

Molecular Genetics of para-Aminosalicylic Acid Resistance in Clinical Isolates and Spontaneous Mutants of Mycobacterium tuberculosis

(2009) V. Mathys et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation

(2009) B. Springer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Synthetic EthR inhibitors boost antituberculous activity of ethionamide

(2009) Nicolas Willand et al.   NATURE MEDICINE

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

(2009) James C. Johnston et al.   PLoS One

Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and Genotyping

(2008) B. Springer et al.   JOURNAL OF CLINICAL MICROBIOLOGY